Amgen (NASDAQ: AMGN) CFO receives new RSUs, options and tax withholding
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Amgen EVP & CFO Peter H. Griffith reported routine equity compensation and related tax withholding. On May 5, 2026, he received 3,640 shares of Common Stock as a grant valued at $0.0000 per share, tied to Restricted Stock Units under Amgen’s Equity Incentive Plan. These RSUs, including 424 Dividend Equivalents, vest in four equal 25% installments starting on May 5, 2027 and will be settled in common shares.
He was also granted 23,752 non-qualified stock options with a $329.59 exercise price, vesting 25% annually from May 5, 2027 and expiring on May 5, 2036. On May 6, 2026, 502 shares of Common Stock were disposed of at $329.59 per share to cover tax obligations. After these transactions, he directly holds 50,706 shares of Amgen common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Griffith Peter H.
Role
EVP & CFO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock | 502 | $329.59 | $165K |
| Grant/Award | Nqso (Right to Buy) | 23,752 | $329.59 | $7.83M |
| Grant/Award | Common Stock | 3,640 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 50,706 shares (Direct, null);
Nqso (Right to Buy) — 23,752 shares (Direct, null)
Footnotes (1)
- The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/5/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. These shares include 424 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/5/2027.
Key Figures
RSU shares granted: 3,640 shares
Dividend Equivalents: 424 units
Non-qualified stock options granted: 23,752 options
+5 more
8 metrics
RSU shares granted
3,640 shares
Restricted Stock Units granted on May 5, 2026
Dividend Equivalents
424 units
Dividend Equivalents credited to unvested RSUs
Non-qualified stock options granted
23,752 options
Options granted May 5, 2026 under Equity Incentive Plan
Option exercise price
$329.59/share
Exercise price for non-qualified stock options
Tax-withholding shares
502 shares
Shares disposed May 6, 2026 for tax withholding
Shares held after transactions
50,706 shares
Direct common stock holdings following Form 4 transactions
RSU vesting start date
May 5, 2027
First 25% vesting installment for RSUs
Option expiration date
May 5, 2036
Expiration of non-qualified stock options
Key Terms
Restricted Stock Units (RSUs), Dividend Equivalents (DEs), non-qualified stock options, Equity Incentive Plan, +1 more
5 terms
Restricted Stock Units (RSUs) financial
"The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan"
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Dividend Equivalents (DEs) financial
"These shares include 424 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan"
non-qualified stock options financial
"These non-qualified stock options were granted pursuant to the Equity Incentive Plan"
Non-qualified stock options are a type of employee benefit that gives individuals the right to buy company shares at a set price, usually lower than the market value, within a certain period. Unlike other options that may have special tax advantages, these options are taxed as income when exercised, which can affect how much money the employee or investor ultimately gains. They are important because they can influence company compensation strategies and impact the financial outcomes for employees and investors.
Equity Incentive Plan financial
"granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan)"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
tax-withholding disposition financial
"Payment of exercise price or tax liability by delivering securities"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
FAQ
What equity awards did Amgen (AMGN) CFO Peter H. Griffith receive?
Amgen’s EVP & CFO Peter H. Griffith received 3,640 Restricted Stock Units and 23,752 non-qualified stock options. The RSUs convert one-to-one into common shares, while the options allow future share purchases at a fixed exercise price of $329.59.
How do Peter H. Griffith’s new Amgen RSUs vest and pay out?
The 3,640 RSUs granted to Peter H. Griffith vest in four equal 25% annual installments starting May 5, 2027. Once vested, each unit is paid out in one share of Amgen common stock, plus cash for any fractional dividend equivalent amounts.
What are the key terms of Peter H. Griffith’s new Amgen stock options?
Griffith’s 23,752 non-qualified stock options have a $329.59 exercise price and expire May 5, 2036. They vest in four equal 25% annual installments beginning May 5, 2027, after which he can exercise them to buy Amgen common stock at that price.
What are Dividend Equivalents in Peter H. Griffith’s Amgen RSU grant?
Dividend Equivalents are additional units credited on unvested RSUs, matching dividends on Amgen shares. Griffith’s holdings include 424 Dividend Equivalents, which will pay out in shares according to the RSU vesting schedule, plus cash for any remaining fractional share amounts.